Phuong Vu
- Research technologist; M.Sc.
- +47 23 02 13 54 ; +47 95 81 97 57
Publications 2023
Oncogenic PKA signaling increases c-MYC protein expression through multiple targetable mechanisms
Elife, 12 (in press)
DOI 10.7554/eLife.69521, PubMed 36692000
Publications 2022
Reply
J Pediatr, 243, 238-239
DOI 10.1016/j.jpeds.2022.01.011, PubMed 35041810
EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion-Positive Cholangiocarcinoma
Cancer Discov, 12 (5), 1378-1395
DOI 10.1158/2159-8290.CD-21-1168, PubMed 35420673
Publications 2019
TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma
Cancer Discov, 9 (8), 1064-1079
DOI 10.1158/2159-8290.CD-19-0182, PubMed 31109923
The prevalence of depression and associated risk factors among medical students: An untold story in Vietnam
PLoS One, 14 (8), e0221432
DOI 10.1371/journal.pone.0221432, PubMed 31430339
Fatal encephalopathy with wild-type JC virus and ruxolitinib therapy
Ann Neurol, 86 (6), 878-884
DOI 10.1002/ana.25608, PubMed 31600832
Publications 2017
The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer
Clin Cancer Res, 23 (16), 4662-4670
DOI 10.1158/1078-0432.CCR-17-0160, PubMed 28487444
Publications 2016
Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma
Cancer Discov, 7 (3), 252-263
DOI 10.1158/2159-8290.CD-16-1000, PubMed 28034880
TP53 Mutation Spectrum in Smokers and Never Smoking Lung Cancer Patients
Front Genet, 7, 85
DOI 10.3389/fgene.2016.00085, PubMed 27242894
Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic Cholangiocarcinoma
Cancer Discov, 6 (7), 727-39
DOI 10.1158/2159-8290.CD-15-1442, PubMed 27231123
Publications 2014
Mutation screening of the TP53 gene by temporal temperature gel electrophoresis (TTGE)
Methods Mol Biol, 1105, 315-24
DOI 10.1007/978-1-62703-739-6_25, PubMed 24623239
Publications 2009
Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolution
Mol Oncol, 3 (3), 214-9
DOI 10.1016/j.molonc.2009.03.001, PubMed 19403344
Publications 2008
A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients
Acta Oncol, 47 (4), 600-7
DOI 10.1080/02841860802047411, PubMed 18465328
TP53 mutations in synchronous and metachronous bilateral breast carcinomas
Cancer Genet Cytogenet, 184 (2), 119-21
DOI 10.1016/j.cancergencyto.2008.03.005, PubMed 18617062
Publications 2007
Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence
Radiat Oncol, 2, 25
DOI 10.1186/1748-717X-2-25, PubMed 17623063
Publications 2005
Mutation screening of the TP53 gene by temporal temperature gradient gel electrophoresis
Methods Mol Biol, 291, 207-16
DOI 10.1385/1-59259-840-4:207, PubMed 15502225